STOCK TITAN

IVVD Insider Notice: 39,600 Shares from Vested RSUs to Be Sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Invivyd, Inc. filed a Form 144 announcing a proposed sale of 39,600 shares of its common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $28,001.16. The filing states the shares were acquired on 08/15/2025 upon vesting of restricted stock units granted under the company’s 2021 Equity Incentive Plan and that payment was classified as Equity Compensation. The filer indicates no sales of the issuer’s securities in the past three months. The approximate date of sale is listed as 08/18/2025 on Nasdaq. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Positive

  • Clear disclosure of broker, share count, aggregate market value, acquisition date, and proposed sale date
  • Source of shares explicitly stated as vested restricted stock units under the 2021 Equity Incentive Plan
  • No reported sales of the issuer's securities by the person in the past three months

Negative

  • Proposed market sale of insider-held shares may increase available float in the near term
  • Form does not identify the specific seller by name or provide further context about the reason for sale

Insights

TL;DR: Routine insider notice of proposed sale of vested RSU shares through a broker, with no prior reported sales in past three months.

This Form 144 documents a planned market sale of 39,600 common shares acquired by vesting of restricted stock units on 08/15/2025, executed via Morgan Stanley Smith Barney LLC and targeted for Nasdaq on 08/18/2025. The filing notes the consideration type as equity compensation and explicitly reports no securities sold by the person in the prior three months. For investors, this is a standard regulatory disclosure that enables public sale under Rule 144; it contains no new financial performance data or disclosures of material adverse information.

TL;DR: Compliance-oriented filing showing an insider converting vested RSUs to common stock and notifying the market of a planned sale.

The filing reflects compliance with Rule 144 procedural requirements: it identifies the broker, the source of the shares

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Invivyd (IVVD) report in this Form 144?

Invivyd reports a proposed sale of 39,600 common shares acquired on 08/15/2025 upon vesting of restricted stock units, with an aggregate market value of $28,001.16.

When is the proposed sale of IVVD shares scheduled?

The approximate sale date is listed as 08/18/2025 on Nasdaq using Morgan Stanley Smith Barney LLC as broker.

How were the shares to be sold acquired?

The shares were acquired on 08/15/2025 upon vesting of restricted stock units granted under Invivyd's 2021 Equity Incentive Plan.

Did the filer report any sales of Invivyd securities in the past three months?

No. The filing states 'Nothing to Report' for securities sold during the past three months by the person for whose account the securities are to be sold.

What attestation does the filer make in the Form 144?

The filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and provides the standard Rule 144 representations.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

733.17M
223.47M
19.2%
60.75%
2.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW HAVEN